Federal authorities convicted a telehealth company founder and clinical president for illegal stimulant prescription ...

The FDA has approved Simtriyo (centanafadine), a first-in-class NDSRI and CNS stimulant, for adult and pediatric ADHD aged 6 years and older.

An outside advisory panel to the FDA is pushing for the production and sale of a few previously banned peptide treatments.

Children and adolescents appear to experience a greater level of psychological burden in association with atopic dermatitis.

Centanafadine XR demonstrated efficacy in improving symptoms in adults with attention-deficit/hyperactivity disorder and comorbid anxiety.

Adolescent non-suicidal self-injury functions as part of a complex, interconnected symptom-risk system rather than as an isolated behavior.

Depressive symptoms were consistently associated with a greater tendency for social media likes to reinforce subsequent posting frequency, underscoring the need to integrate in-laboratory and ...

Almost 25% of workers in the US report staying in a job they do not want in order to maintain health care coverage.

Some doctors are concerned about the accessibility of poorly labeled THC-based beverages, while others see a potential alcohol alternative.

Patients and physiotherapists weigh physical and psychosocial factors differently when assessing recovery from chronic low back pain.

Task-sharing mental health care with non-specialist providers benefits adults with psychologic distress after experiencing violence.

Treatments for fibrodysplasia ossificans progressiva, gastroenteropancreatic neuroendocrine tumors, HIV, influenza, and multiple myeloma are under review.